Aziz Gauhar

Aziz Gauhar worked as a Senior Principal Scientist at Ossianix starting in January 2019. Before that, they were a Sr. Scientist/Project Manager at Treamid Therapeutics from 2017 to 2018. Prior to that, they worked as a Postdoctoral Associate at Universitätsklinikum Düsseldorf from 2016 to 2017.

Aziz Gauhar has a Master of Business Administration (MBA) degree from Düsseldorf Business School, a Doctor of Philosophy (PhD) degree in Biochemistry Drug Discovery from the University of Düsseldorf, and a Master's degree in Biomedical Sciences from Bonn-Rhein-Sieg University of Applied Sciences.